BR9712308A - Inibidor de catarata secundária - Google Patents

Inibidor de catarata secundária

Info

Publication number
BR9712308A
BR9712308A BR9712308-0A BR9712308A BR9712308A BR 9712308 A BR9712308 A BR 9712308A BR 9712308 A BR9712308 A BR 9712308A BR 9712308 A BR9712308 A BR 9712308A
Authority
BR
Brazil
Prior art keywords
secondary cataract
inhibitor
cataract
cataract inhibitor
dimethoxycinnamyl
Prior art date
Application number
BR9712308-0A
Other languages
English (en)
Inventor
Masayuki Isaji
Hiroshi Miyata
Yukiyoshi Ajisawa
Original Assignee
Kissie Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissie Pharmaceutical Co Ltd filed Critical Kissie Pharmaceutical Co Ltd
Publication of BR9712308A publication Critical patent/BR9712308A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"INIBIDOR DE CATARATA SECUNDáRIA" Inibidor de catarata secundária contendo como ingrediente ativo ácido N-(3,4-dimetoxicinamoil) antranílico representado pela fórmula (I) ou os sais farmaceuticamente aceitáveis do mesmo; eficazes na inibição, por exemplo, da turvação capsular posterior após operação da catarata e útil na prevenção ou cura da catarata secundária.
BR9712308-0A 1996-10-14 1997-10-09 Inibidor de catarata secundária BR9712308A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30695296 1996-10-14
PCT/JP1997/003630 WO1998016214A1 (fr) 1996-10-14 1997-10-09 Inhibiteur de la cataracte secondaire

Publications (1)

Publication Number Publication Date
BR9712308A true BR9712308A (pt) 1999-08-31

Family

ID=17963256

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712308-0A BR9712308A (pt) 1996-10-14 1997-10-09 Inibidor de catarata secundária

Country Status (14)

Country Link
US (1) US6376543B1 (pt)
EP (1) EP0958815A4 (pt)
KR (1) KR20000049136A (pt)
CN (1) CN1111403C (pt)
AU (1) AU745028B2 (pt)
BR (1) BR9712308A (pt)
CA (1) CA2267320A1 (pt)
CZ (1) CZ127999A3 (pt)
EA (1) EA001745B1 (pt)
HU (1) HUP9904617A3 (pt)
IL (1) IL129421A0 (pt)
NO (1) NO991627L (pt)
NZ (1) NZ335042A (pt)
WO (1) WO1998016214A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6748398A (en) * 1997-04-18 1998-11-13 Kissei Pharmaceutical Co. Ltd. Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
WO2004058289A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
WO2006073126A1 (ja) * 2005-01-06 2006-07-13 Kissei Pharmaceutical Co., Ltd. 慢性移植片対宿主症におけるドライアイの予防および治療剤
AU2006270094A1 (en) * 2005-07-15 2007-01-25 Chakshu Research Inc. Prevention and treatment of ophthalmic complications of diabetes
CN101652150B (zh) * 2006-12-01 2013-12-11 韦克福里斯特大学健康科学院 结合胶原抑制剂的医疗装置
US8614233B2 (en) 2007-05-29 2013-12-24 Universite De Montreal Cinnamoyl inhibitors of transglutaminase
EP2448948A4 (en) * 2009-07-02 2013-04-10 Oxigene Inc COMBRETASTATINE FOR PREVENTING FUTURE
US9844556B2 (en) 2015-03-25 2017-12-19 Megumi Honjo Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery
RU2622606C1 (ru) * 2016-08-11 2017-06-16 Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Способ медикаментозного лечения вторичной катаракты

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
FR2693107B1 (fr) * 1992-07-01 1994-09-23 Chauvin Laboratoire Moyens pour la prévention de la cataracte secondaire.
JPH09505057A (ja) * 1993-11-19 1997-05-20 ザ・ユニバーシティ・オブ・シドニー 白内障を予防または制御するための方法
BR9707514A (pt) * 1996-02-15 1999-07-27 Kissei Pharmaceutical Inibidor de neovascularizacão

Also Published As

Publication number Publication date
NZ335042A (en) 2001-01-26
EA001745B1 (ru) 2001-08-27
AU4471897A (en) 1998-05-11
AU745028B2 (en) 2002-03-07
EP0958815A4 (en) 2001-02-07
WO1998016214A1 (fr) 1998-04-23
NO991627D0 (no) 1999-04-06
US6376543B1 (en) 2002-04-23
EP0958815A1 (en) 1999-11-24
NO991627L (no) 1999-06-03
EA199900374A1 (ru) 1999-12-29
CN1233172A (zh) 1999-10-27
HUP9904617A3 (en) 2000-07-28
CZ127999A3 (cs) 1999-07-14
CN1111403C (zh) 2003-06-18
CA2267320A1 (en) 1998-04-23
IL129421A0 (en) 2000-02-17
KR20000049136A (ko) 2000-07-25
HUP9904617A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9712308A (pt) Inibidor de catarata secundária
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
BR9712321A (pt) Aminotiofenocarboxamidas
BRPI0213522C1 (pt) compostos derivados de hidroxipirimidinona, composição farmacêutica, e, uso de um composto
BR0209267A (pt) Pirimidinas fundidas como antagonistas do fator de liberação de corticotropina (crf)
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
BR0209468A (pt) Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar
PA8529501A1 (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
ES2131373T3 (es) Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
AR004214A1 (es) Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas
NZ309151A (en) a 3-substituted cyano or carbamoyl pyrrole derivative and pharmaceutical composition
ATE215952T1 (de) Hiv-proteaseinhibitoren
DK1001792T3 (da) Anvendelse af fysiologisk acceptable vanadiumforbindelser, -salte og -komplekser
BR9907715A (pt) Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose
BR0212031A (pt) Preparados de combinação de derivados de 1,1-dióxido de 1-4-benzotiepina com outras substâncias ativas e seu emprego
ATE109006T1 (de) Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
SE8901149D0 (sv) Medel foer inducering respektive foerhindrande av pupillkonstriktion i oegat
DE69614508T2 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
PT1330246E (pt) Utilizacao de derivados do acido hidroxieicosatetraenoico em cirurgia intraocular
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
WO2002096359A3 (en) Piperazine pentanamide hiv protease inhibitors
FR2803521B1 (fr) Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose
EA199800575A1 (ru) Производные пиперазина
BR0207535A (pt) Derivados propano-1,3-diamina substituìdos e o seu emprego farmacêutico

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]